ACAT1 and nonpapillary renal cell carcinoma: In conclusion, we built a co-expression network and identified the ACAT1 related to the progression of ccRCC, which might have important clinical significance in improving risk stratification, treatment decision-making and prognosis prediction in ccRCC patients.